These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 16002531)
1. The new biology of aldosterone. Connell JM; Davies E J Endocrinol; 2005 Jul; 186(1):1-20. PubMed ID: 16002531 [TBL] [Abstract][Full Text] [Related]
2. Hypertension and the expanding role of aldosterone. Mackenzie SM; Connell J Curr Hypertens Rep; 2006 Jun; 8(3):255-61. PubMed ID: 17147925 [TBL] [Abstract][Full Text] [Related]
3. [Endothelial action of aldosterone--therapeutic implications from basic and clinical research]. Drelicharz L; Mikita J; Chabielska E; Chłopicki S Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S409-19. PubMed ID: 20527396 [TBL] [Abstract][Full Text] [Related]
4. Aldosterone and mineralocorticoid receptors in the cardiovascular system. Funder JW Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957 [TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. Young MJ; Funder JW J Hypertens; 2002 Aug; 20(8):1465-8. PubMed ID: 12172301 [TBL] [Abstract][Full Text] [Related]
6. Genomic and rapid effects of aldosterone: what we know and do not know thus far. Hermidorff MM; de Assis LV; Isoldi MC Heart Fail Rev; 2017 Jan; 22(1):65-89. PubMed ID: 27942913 [TBL] [Abstract][Full Text] [Related]
7. Role of mineralocorticoid receptor antagonists in cardiovascular disease. Ferrario CM; Schiffrin EL Circ Res; 2015 Jan; 116(1):206-13. PubMed ID: 25552697 [TBL] [Abstract][Full Text] [Related]
8. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism. Chrissobolis S Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785 [TBL] [Abstract][Full Text] [Related]
10. Aldosterone and its mechanism of action: more questions than answers. Fuller PJ Aust N Z J Med; 1995 Dec; 25(6):800-7. PubMed ID: 8770356 [TBL] [Abstract][Full Text] [Related]
15. New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention. Kolodziejczyk P; Gromotowicz-Poplawska A; Aleksiejczuk M; Chabielska E; Tutka P; Miltyk W Curr Drug Targets; 2018; 19(16):1968-1979. PubMed ID: 29577853 [TBL] [Abstract][Full Text] [Related]
16. Adverse Effects of Aldosterone: Beyond Blood Pressure. Brown JM J Am Heart Assoc; 2024 Apr; 13(7):e030142. PubMed ID: 38497438 [TBL] [Abstract][Full Text] [Related]
17. [Aldosterone: the mechanisms of molecular action]. Logvinenko NS Ross Fiziol Zh Im I M Sechenova; 2007 Jul; 93(7):746-61. PubMed ID: 17912848 [TBL] [Abstract][Full Text] [Related]
19. Aldosterone receptor antagonists: current perspectives and therapies. Guichard JL; Clark D; Calhoun DA; Ahmed MI Vasc Health Risk Manag; 2013; 9():321-31. PubMed ID: 23836977 [TBL] [Abstract][Full Text] [Related]
20. Aldosterone and specific aldosterone receptor antagonists in hypertension and cardiovascular disease. Bravo EL Curr Hypertens Rep; 2003 Apr; 5(2):122-5. PubMed ID: 12642011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]